Automation of the Hereditary Cancer Solution by SOPHiA GENETICS on a STARlet

Download our new Application Note about the automation of the HCS by SOPHiA GENETICS, the first capture-based application, which has received the CE-IVD mark.

This protocol is frequently requested in the field, especially in the clinical environment where minimizing human intervention is a plus.

During this validation study, all confirmed variants (SNVs and Indels) were reliably called and all CNVs have been detected, including gene conversion events in PMS2/PMS2CL.

This app note describes the automation of 2 protocol steps, whole genome library preparation & target capture, with Pre & Post-PCR workflows performed on the same deck layout.